# Exercise Treatment With Standard Therapy for Metastatic Breast Cancer

> **NCT03988595** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 54 (actual)

## Conditions studied

- Hormone Receptor Positive Metastatic Breast Cancer

## Interventions

- **OTHER:** Exercise Treatment

## Key facts

- **NCT ID:** NCT03988595
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-06-12
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2025-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03988595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03988595, "Exercise Treatment With Standard Therapy for Metastatic Breast Cancer". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03988595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*